LeMaitre Vascular Newsroom

A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $92 to $115

Moomoo NewsMay 3 09:00 ET

Lemaitre Vascular (LMAT) Gets a Buy From Stifel Nicolaus

TipRanksMay 2 07:56 ET

KeyBanc Maintains LeMaitre Vascular(LMAT.US) With Hold Rating

Moomoo NewsMay 2 06:31 ET

Cantor Fitzgerald Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Maintains Target Price $96

Moomoo NewsMay 1 01:33 ET

Analysts Conflicted on These Healthcare Names: Tenet Healthcare (THC), Incyte (INCY) and Lemaitre Vascular (LMAT)

TipRanksApr 30 08:47 ET

Barrington Maintains LeMaitre Vascular(LMAT.US) With Hold Rating

Moomoo NewsApr 22 01:32 ET

Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT) and UnitedHealth (UNH)

TipRanksApr 21 07:52 ET

Cantor Fitzgerald Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Maintains Target Price $96

Moomoo NewsMar 19 01:33 ET

Cantor Fitzgerald Maintains LeMaitre Vascular(LMAT.US) With Hold Rating, Maintains Target Price $96

Moomoo NewsMar 10 10:31 ET

A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $106 to $115

Moomoo NewsMar 1 08:01 ET

Analysts Are Bullish on Top Healthcare Stocks: 89bio (ETNB), Lemaitre Vascular (LMAT)

TipRanksFeb 28 15:59 ET

LeMaitre Vascular Is Maintained at Buy by Lake Street

Dow JonesFeb 28 12:12 ET

Stifel Nicolaus Keeps Their Buy Rating on Lemaitre Vascular (LMAT)

TipRanksFeb 28 08:57 ET

Analysts Conflicted on These Healthcare Names: Lemaitre Vascular (LMAT), Catalyst Pharma (CPRX) and Nektar Therapeutics (NKTR)

TipRanksFeb 28 08:17 ET

Oppenheimer Downgrades LeMaitre Vascular to Market Perform From Overweight, Price Target Is $45

MT NewswiresFeb 28 08:04 ET

LeMaitre Vascular Analyst Ratings

BenzingaFeb 28 07:42 ET

KeyBanc Maintains LeMaitre Vascular(LMAT.US) With Hold Rating

Moomoo NewsFeb 28 03:33 ET

KeyBanc Reaffirms Their Hold Rating on Lemaitre Vascular (LMAT)

TipRanksFeb 28 02:51 ET

JMP Securities Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $113

Moomoo NewsFeb 28 01:31 ET

Lemaitre Vascular: Strong Financial Performance and Promising Prospects Justify Buy Rating and Raised Price Target

TipRanksFeb 28 01:21 ET